Jon intimated in the PHS webinar an announcement about the undisclosed indications was months away (from May) so I think they will come out after the FDA meeting at the end of this quarter. To me, it would seem likely they will be announced in tandem with what their trial pathway is. Combine this with how Phase 3 will progress and you will know exactly what Neuren holds.
If the FDA meeting is successful I think things will move quickly.
- Forums
- ASX - By Stock
- Neuren Media and Analyst Coverage
Jon intimated in the PHS webinar an announcement about the...
-
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$14.07 |
Change
-0.400(2.76%) |
Mkt cap ! $1.798B |
Open | High | Low | Value | Volume |
$14.47 | $14.53 | $13.99 | $7.843M | 552.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2150 | $14.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.10 | 1129 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 698 | 14.770 |
1 | 50 | 14.480 |
1 | 1000 | 14.150 |
1 | 319 | 14.100 |
2 | 2010 | 14.060 |
Price($) | Vol. | No. |
---|---|---|
13.370 | 1831 | 3 |
13.640 | 8 | 1 |
13.800 | 115 | 1 |
13.860 | 3 | 1 |
13.990 | 300 | 1 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |